{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T12:33:26Z","timestamp":1766493206267,"version":"3.40.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Genetics and Genomics Advances"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.xhgg.2024.100394","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T16:46:28Z","timestamp":1734453988000},"page":"100394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A recurrent variant in PPP2R5C identified in individuals with macrocephaly, intellectual disability, and seizures"],"prefix":"10.1016","volume":"6","author":[{"given":"Alison M.","family":"Muir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adi","family":"Reich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanggeng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanna Alexis","family":"Carere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue Moyer","family":"Harasink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0882-1016","authenticated-orcid":false,"given":"Bobbi","family":"McGivern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xhgg.2024.100394_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188953","article-title":"Regulation and role of the PP2A-B56 holoenzyme family in cancer","volume":"1878","author":"Peris","year":"2023","journal-title":"Biochim. Biophys. Acta. Rev. Cancer"},{"key":"10.1016\/j.xhgg.2024.100394_bib2","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.248187","article-title":"Protein phosphatase 2A - structure, function and role in neurodevelopmental disorders","volume":"134","author":"Sandal","year":"2021","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.xhgg.2024.100394_bib3","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2006.11.033","article-title":"Structure of the protein phosphatase 2A holoenzyme","volume":"127","author":"Xu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.xhgg.2024.100394_bib4","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1172\/JCI79860","article-title":"B56delta-related protein phosphatase 2A dysfunction identified in patients with intellectual disability","volume":"125","author":"Houge","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xhgg.2024.100394_bib5","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1093\/hmg\/ddv182","article-title":"Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth","volume":"24","author":"Loveday","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xhgg.2024.100394_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ajhg.2018.12.002","article-title":"De Novo Mutations Affecting the Catalytic Calpha Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders","volume":"104","author":"Reynhout","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xhgg.2024.100394_bib7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/gim.2015.148","article-title":"Clinical application of whole-exome sequencing across clinical indications","volume":"18","author":"Retterer","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.xhgg.2024.100394_bib8","series-title":"Encyclopedia of Autism Spectrum Disorders","article-title":"Autism Spectrum Rating Scale","author":"Goldstein","year":"2020"},{"key":"10.1016\/j.xhgg.2024.100394_bib9","series-title":"Encyclopedia of Clinical Neuropsychology","article-title":"Adaptive Behavior Assessment System","author":"Harrison","year":"2018"},{"key":"10.1016\/j.xhgg.2024.100394_bib10","series-title":"The Encyclopedia of Clinical Psychology","first-page":"1","article-title":"Behavior Assessment System for Children","author":"Kamphaus","year":"2015"},{"year":"2013","series-title":"ADOS-2","author":"Schedule","key":"10.1016\/j.xhgg.2024.100394_bib11"},{"year":"2010","series-title":"Childhood Autism Rating Scale","author":"Schopler","key":"10.1016\/j.xhgg.2024.100394_bib12"},{"key":"10.1016\/j.xhgg.2024.100394_bib13","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1074\/jbc.271.5.2578","article-title":"High complexity in the expression of the B' subunit of protein phosphatase 2A0. Evidence for the existence of at least seven novel isoforms","volume":"271","author":"Csortos","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xhgg.2024.100394_bib14","doi-asserted-by":"crossref","first-page":"22081","DOI":"10.1074\/jbc.271.36.22081","article-title":"The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm","volume":"271","author":"McCright","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xhgg.2024.100394_bib15","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41588-022-01104-0","article-title":"Rare coding variation provides insight into the genetic architecture and phenotypic context of autism","volume":"54","author":"Fu","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xhgg.2024.100394_bib16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41586-020-2832-5","article-title":"Evidence for 28 genetic disorders discovered by combining healthcare and research data","volume":"586","author":"Kaplanis","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xhgg.2024.100394_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/genes14030708","article-title":"High Performance of a Dominant\/X-Linked Gene Panel in Patients with Neurodevelopmental Disorders","volume":"14","author":"Spataro","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.xhgg.2024.100394_bib18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1503\/jpn.180184","article-title":"Truncating variant burden in high-functioning autism and pleiotropic effects of LRP1 across psychiatric phenotypes","volume":"44","author":"Torrico","year":"2019","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.xhgg.2024.100394_bib19","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.ajhg.2019.11.003","article-title":"Sex-Based Analysis of De Novo Variants in Neurodevelopmental Disorders","volume":"105","author":"Turner","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xhgg.2024.100394_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/bj3530417","article-title":"Protein phosphatase 2A: a highly regulated family of serine\/threonine phosphatases implicated in cell growth and signalling","volume":"353","author":"Janssens","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.xhgg.2024.100394_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10048-015-0466-9","article-title":"De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism","volume":"17","author":"Shang","year":"2016","journal-title":"Neurogenetics"},{"key":"10.1016\/j.xhgg.2024.100394_bib22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/jmg-2022-108713","article-title":"Clinical, neuroimaging and molecular characteristics of PPP2R5D-related neurodevelopmental disorders: an expanded series with functional characterisation and genotype-phenotype analysis","volume":"60","author":"Oyama","year":"2023","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.xhgg.2024.100394_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100313","article-title":"A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth","volume":"296","author":"Papke","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xhgg.2024.100394_bib24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/jmg.2007.049981","article-title":"Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers","volume":"44","author":"Lachlan","year":"2007","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.xhgg.2024.100394_bib25","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ng.2331","article-title":"De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes","volume":"44","author":"Riviere","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xhgg.2024.100394_bib26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ng.2948","article-title":"De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome","volume":"46","author":"Mirzaa","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xhgg.2024.100394_bib27","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jamaneurol.2016.0363","article-title":"Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism","volume":"73","author":"Mirzaa","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.xhgg.2024.100394_bib28","series-title":"GeneReviews\u00ae [Internet]","article-title":"Spinocerebellar Ataxia Type 6","author":"Casey","year":"2019"}],"container-title":["Human Genetics and Genomics Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666247724001349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666247724001349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T17:51:05Z","timestamp":1744998665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666247724001349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2666247724001349"],"URL":"https:\/\/doi.org\/10.1016\/j.xhgg.2024.100394","relation":{},"ISSN":["2666-2477"],"issn-type":[{"type":"print","value":"2666-2477"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A recurrent variant in PPP2R5C identified in individuals with macrocephaly, intellectual disability, and seizures","name":"articletitle","label":"Article Title"},{"value":"Human Genetics and Genomics Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xhgg.2024.100394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society of Human Genetics.","name":"copyright","label":"Copyright"}],"article-number":"100394"}}